Novel Gemcitabine-Re(I) Bisquinolinyl Complex Combinations and Formulations With Liquid Crystalline Nanoparticles for Pancreatic Cancer Photodynamic Therapy

With less than 10% of 5-year survival rate, pancreatic ductal adenocarcinoma (PDAC) is known to be one of the most lethal types of cancer. Current literature supports that gemcitabine is the first-line treatment of PDAC. However, poor cellular penetration of gemcitabine along with the acquired and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Liew, Hui Shan, Mai, Chun-Wai, Zulkefeli, Mohd, Madheswaran, Thiagarajan, Kiew, Lik Voon, Pua, Lesley Jia Wei, Hii, Ling Wei, Lim, Wei Meng, Low, May Lee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299370/
https://www.ncbi.nlm.nih.gov/pubmed/35873548
http://dx.doi.org/10.3389/fphar.2022.903210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299370/
https://www.ncbi.nlm.nih.gov/pubmed/35873548
http://dx.doi.org/10.3389/fphar.2022.903210

Ejemplares similares